It primarily develops TSHA-120 for the treatment of giant axonal neuropathy; TSHA-102 for the treatment of Rett syndrome; TSHA-121 for the treatment of CLN7 disease; TSHA-118 for the treatment of CLN1 ...

This multifaceted inhibition improves synaptic transmission and axonal transport, reduces neuroinflammation, and... corporate communications solutions . With broad reach and a seasoned team of ...

Karl Fitzpatrick has described his frightening ordeal after being diagnosed with potentially life-threatening Guillain–Barré ...

The plea says the petitioner's family has done its best to treat him. However, he has been confined to bed by a diffuse ...

People with a high number of antiseizure medications seem to be at risk for accelerated neuroaxonal loss. HealthDay News — In people with epilepsy, progression of retinal neuroaxonal loss is ...

This study presents a valuable finding on the molecular mechanisms that govern GABAergic inhibitory synapse function. The authors propose that Endophilin A1 serves as a novel regulator of GABAergic ...

Vigil Neuroscience, Inc. (Nasdaq: VIGL), a clinical-stage biotechnology company committed to harnessing the power of ...

The Supreme Court has come to the help of the distraught parents of a 30-year-old man, who has been in a permanent vegetative state for over 11 years following a severe head injury, by ensuring ...

This important paper takes a novel approach to the problem of automatically reconstructing long-range axonal projections from stacks of images. The key innovation is to separate the identification of ...

The investigators added that inflammation and demyelination were reduced, while axonal density oligodendrocytes, ...

It primarily develops TSHA-120 for the treatment of giant axonal neuropathy; TSHA-102 for the treatment of Rett syndrome; TSHA-121 for the treatment of CLN7 disease; TSHA-118 for the treatment of CLN1 ...

Mapping cell types in MS lesions reveals unique tissue niches and interactions, offering insights into the molecular drivers ...